223 related articles for article (PubMed ID: 31122202)
61. [The WHO/ISUP grading system for renal carcinoma].
Moch H
Pathologe; 2016 Jul; 37(4):355-60. PubMed ID: 27271258
[TBL] [Abstract][Full Text] [Related]
62. Comparison of utility of tumor size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma.
Maruyama M; Yoshizako T; Uchida K; Araki H; Tamaki Y; Ishikawa N; Shiina H; Kitagaki H
Acta Radiol; 2015 Feb; 56(2):250-6. PubMed ID: 24518687
[TBL] [Abstract][Full Text] [Related]
63. Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma.
Zhu YH; Wang X; Zhang J; Chen YH; Kong W; Huang YR
AJR Am J Roentgenol; 2014 Sep; 203(3):W295-300. PubMed ID: 25148187
[TBL] [Abstract][Full Text] [Related]
64. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
65. Cyst-associated renal cell carcinoma: clinicopathologic characteristics and evaluation of prognosis in 27 cases.
Onishi T; Oishi Y; Goto H; Tomita M; Abe K; Sugaya S
Int J Urol; 2001 Jun; 8(6):268-74. PubMed ID: 11389741
[TBL] [Abstract][Full Text] [Related]
66. Aligned collagen is a prognostic signature for survival in human breast carcinoma.
Conklin MW; Eickhoff JC; Riching KM; Pehlke CA; Eliceiri KW; Provenzano PP; Friedl A; Keely PJ
Am J Pathol; 2011 Mar; 178(3):1221-32. PubMed ID: 21356373
[TBL] [Abstract][Full Text] [Related]
67. Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma.
Chapman-Fredricks JR; Herrera L; Bracho J; Gomez-Fernandez C; Leveillee R; Rey L; Jorda M
Ann Diagn Pathol; 2011 Oct; 15(5):333-7. PubMed ID: 21665507
[TBL] [Abstract][Full Text] [Related]
68. Comparison of Utility of Histogram Apparent Diffusion Coefficient and R2* for Differentiation of Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma.
Zhang YD; Wu CJ; Wang Q; Zhang J; Wang XN; Liu XS; Shi HB
AJR Am J Roentgenol; 2015 Aug; 205(2):W193-201. PubMed ID: 26204307
[TBL] [Abstract][Full Text] [Related]
69. Intensity-based registration of bright-field and second-harmonic generation images of histopathology tissue sections.
Keikhosravi A; Li B; Liu Y; Eliceiri KW
Biomed Opt Express; 2020 Jan; 11(1):160-173. PubMed ID: 32010507
[TBL] [Abstract][Full Text] [Related]
70. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
[TBL] [Abstract][Full Text] [Related]
71. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma.
Lin F; Zhang PL; Yang XJ; Shi J; Blasick T; Han WK; Wang HL; Shen SS; Teh BT; Bonventre JV
Am J Surg Pathol; 2007 Mar; 31(3):371-81. PubMed ID: 17325478
[TBL] [Abstract][Full Text] [Related]
72. Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.
Minamimoto R; Nakaigawa N; Nagashima Y; Toyohara J; Ueno D; Namura K; Nakajima K; Yao M; Kubota K
Abdom Radiol (NY); 2016 Mar; 41(3):521-30. PubMed ID: 27039323
[TBL] [Abstract][Full Text] [Related]
73. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
[TBL] [Abstract][Full Text] [Related]
74. The value of blood oxygenation level-dependent (BOLD) MR imaging in differentiation of renal solid mass and grading of renal cell carcinoma (RCC): analysis based on the largest cross-sectional area versus the entire whole tumour.
Wu GY; Suo ST; Lu Q; Zhang J; Zhu WQ; Xu JR
PLoS One; 2015; 10(4):e0123431. PubMed ID: 25875306
[TBL] [Abstract][Full Text] [Related]
75. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
[TBL] [Abstract][Full Text] [Related]
76. Under-grading of <4 cm renal masses on renal biopsy.
Harris CR; Whitson JM; Meng MV
BJU Int; 2012 Sep; 110(6):794-7. PubMed ID: 22404857
[TBL] [Abstract][Full Text] [Related]
77. Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.
Parada Villavicencio C; Mc Carthy RJ; Miller FH
Abdom Radiol (NY); 2017 Apr; 42(4):1241-1249. PubMed ID: 27904923
[TBL] [Abstract][Full Text] [Related]
78. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
[TBL] [Abstract][Full Text] [Related]
79. Gleason and Fuhrman no longer make the grade.
Delahunt B; Egevad L; Samaratunga H; Martignoni G; Nacey JN; Srigley JR
Histopathology; 2016 Mar; 68(4):475-81. PubMed ID: 26266664
[TBL] [Abstract][Full Text] [Related]
80. Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
Wan YP; Xi M; He HC; Wan S; Hua W; Zen ZC; Liu YL; Zhou YL; Mo RJ; Zhuo YJ; Luo HW; Jiang FN; Zhong WD
Oncol Res Treat; 2017; 40(1-2):15-20. PubMed ID: 28118628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]